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The caspase family of enzymes participates in apoptotic
and proinflammatory reactions in any cell. Here we studied
the role of caspase activation in the tubular epithelium of
diseased kidneys using mice transgenic for the baculovirus
pan-caspase inhibitor p35 gene held in a nonexpressed
state (control mice) but target-expressed in the renal
proximal tubule cells when crossed with mice expressing Cre
recombinase under the control of the c-glutamyltransferase
promoter. Proinflammatory and profibrogenic parameters
such as the number of monocytes and fibroblasts in the
kidneys were significantly increased at 28 days in the control
mice, but not in the renal tubule–targeted mice expressing
p35 in a nephrotoxic serum nephritis model of disease.
These cellular changes paralleled the number of apoptotic
tubular cells and protein levels of active caspase-3 in the
kidneys at 7 and 28 days of both the control and proximal
tubule–targeted mice. Surprisingly, all of these parameters
were not significantly affected at 7 and 28 days by targeted
p35 expression in tubular epithelium when compared
with nontargeted control mice in a model of adriamycin
nephrosis. Thus, our study shows the critical role of caspase
activation in the tubular epithelium in apoptosis along
with proinflammatory and profibrogenic processes in
nephrotoxic serum nephritis but not adriamycin nephrosis.
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Caspases are evolutionarily conserved enzymes that execute
the function of programmed cell death in normal develop-
ment. They have also been implicated in a variety of patho-
logical conditions including cerebral ischemia, myocardial
infarction, and ischemia–reperfusion injury in the kidney.1–4
In the caspase-dependent apoptotic pathway, caspase-8 acti-
vation by ligation of death receptors causes direct caspase-3
activation, mitochondrial injury, and cytochrome c release,
the latter of which then also triggers the activation of
caspase-9 and caspase-3.5 The activation of caspase-3 results
in widespread proteolysis and cell death. Caspase-1 also
contributes to ischemic damage through its ability to activate
inflammasome and cleave the precursor of interleukin
(IL)-1b to release an active subunit, a component of innate
immunity.6 An involvement of caspases in the pathogenesis
of kidney diseases was tested in in vivo experiments with
systemic caspase inhibition. This revealed that treatment
with caspase inhibitors significantly attenuated progression
of kidney diseases such as ischemia–reperfusion injury,4
obstructive nephropathy,7 polycystic kidney disease,8 lupus
nephritis,9 and nephrotoxic serum nephritis (NTN).10 In
these studies, caspase-dependent apoptosis was considered a
target in the treatment with caspase inhibitors. However, the
cells principally involved in caspase activation have not been
identified in the kidney diseases. Moreover, systemic admin-
istration of inhibitors that disrupt caspase activation also
impair host innate immunity, resolution of inflam-
mation, and restraining tissue hyperplasia including tumori-
genesis.6,11,12 Therefore, the ideal, preferred therapeutic
modality lies in a targeted, tissue-specific inhibition of cas-
pase activity. Thus, we aimed to determine whether tubular
epithelium in a nephritic kidney could serve as an ideal target
for caspase inhibition reflected in suppressing renal injuries
in NTN13 and in a nephrotic syndrome of adriamycin
nephropathy (ADR),14 which has never been tested for
caspase inhibition. In this study, we used a transgenic (TG)
mouse bearing the baculovirus-derived, pan-caspase inhibi-
tor protein p35 gene separated from the universal CAG
promoter by a floxed STOP sequence.15 To inhibit caspase
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activities exclusively in the tubular cells, this p35 mouse
was mated with another TG mouse carrying Cre recombinase
gene under the control of a g-glutamyl transferase (gGT)
promoter that is active only in the proximal tubular
epithelium in the kidney.16
RESULTS
Renal pathology in cGT.Cre;p35 mice with NTN and ADR
In this study, NTN and ADR models were generated in p35 TG
mice of SJL and 129 backgrounds, respectively. These mice were
selected because they represented the mouse strains most
susceptible to each disease.13,14 At first, we tested whether p35
expression was exclusively restricted within the tubules of
control and diseased kidneys of gGT.Cre;p35 F1 mice. As
expected, gGT promoter–driven p35þ proximal tubular
epithelia were found in the normal and diseased kidneys of
gGT.Cre;p35 mice of both strains (Figure 1a and b).
gGT.Cre;p35-NTN mice displayed significantly less tubular
degeneration at 7 and 28 days and narrower extracellular matrix
deposition at 28 days in the interstitium than in the p35-NTN
mice as the positive controls (Figure 1c, e and f). In contrast, at
7 and 28 days, there were no differences in tubular degeneration
and extracellular matrix deposition between gGT.Cre;p35-ADR
and p35-ADR mice (Figure 1d–f). It is interesting to note that
p35 expressed in the tubules did not significantly affect
glomerular damages in those mice with NTN and ADR (Figure
1c, d and g). Consistent with these observations, at 28 days,
serum creatinine levels were significantly lower in the
gGT.Cre;p35-NTN mice than in the p35-NTN mice (serum
creatinine, 0.19±0.05 vs. 0.35±0.05 mg/dl, Po0.05), whereas
urinary protein excretion levels were not different between them
(proteinuria, 35.5±15.8 vs. 40.0±18.3 mg/mg creatinine; data
not shown in figure). For the nephrotic groups, no significant
differences in those levels were seen between gGT.Cre;p35-ADR
and p35-ADR mice (serum creatinine, 0.25±0.07 vs.
0.21±0.06 mg/dl; proteinuria, 83.3±20.9 vs. 85.5±25.5 mg/
mg creatinine; data not shown in figure).
Renal inflammation in cGT.Cre;p35 mice with NTN and ADR
To determine whether tubular caspase activation is involved
in inflammation in the nephritic and nephrotic kidneys,
immunohistochemistry and proinflammatory gene expres-
sion analysis were performed. For nephritic kidneys, at 28
days, gGT.Cre;p35-NTN mice displayed significantly less
F4/80þ monocyte infiltration into the interstitium than in
p35-NTN mice (Figure 2a and c). In contrast, monocyte
infiltration was not attenuated in the D7 and D28 nephrotic
kidneys of gGT.Cre;p35-ADR mice compared with p35-ADR
mice (Figure 2b and c). Consistent with the number of
monocytes, induced expression of proinflammatory genes
such as monocyte chemoattractant protein-1 (MCP-1) and
tumor necrosis factor-a (TNF-a) in the D7 and D28
nephritic kidneys were significantly lower in gGT.Cre;p35-
NTN mice than in p35-NTN mice. In contrast, there were no
differences in those expressions in the D7 and D28 nephrotic
mice between gGT.Cre;p35-ADR and p35-ADR mice (Figure
2d). Protein levels of the active subunit of IL-1b (B17 kDa)
were also significantly higher at 28 days in the p35-NTN mice
than those in the gGT.Cre;p35-NTN mice (Figure 2e). At the
same time points, no differences in those levels were seen in
the gGT.Cre;p35-ADR and p35-ADR mice (Figure 2e).
Renal fibrogenesis in cGT.Cre;p35 mice with NTN and ADR
We next tested whether caspase activation in the tubules is
involved in fibrogenesis in the nephritic and nephrotic
kidneys. At 28 days, the gGT.Cre;p35-NTN mice displayed a
significant reduction in the number of fibroblast-specific
protein 1þ (FSP1þ ) fibroblasts in the interstitium when
compared with the p35-NTN mice (Figure 3a and c). In
contrast, at the same time point, the number of FSP1þ
fibroblasts was not reduced in the gGT.Cre;p35-ADR mice
when compared with the p35-ADR mice (Figure 3b and c).
Consistent with the number of fibroblasts, at 7 and 28 days
the expressions of profibrogenic genes such as plasminogen
activator inhibitor-1 (PAI-1), fibronectin EIIIA isoform (FN-
EIIIA), and a1 procollagen type I (a1COLI) were signifi-
cantly lower in the gGT.Cre;p35-NTN mice than in the p35-
NTN mice. In contrast, the expression levels of these
profibrogenic genes were gradually increased in the D7 and
D28 nephrotic kidneys, and there were no significant
differences in those expressions between the gGT.Cre;p35-
ADR and p35-ADR mice (Figure 3d). These results were also
compatible with the expansion of extracellular matrix
deposition shown in Figure 1c, d and f.
Tubular cell apoptosis in cGT.Cre;p35 mice with NTN and ADR
Apoptotic cells were detected in situ by immunohisto-
chemistry with an antibody against single-stranded DNA.17
Positively stained nuclei in tubules and glomeruli were
quantitatively measured by a point-counting method
described below. Very few apoptotic cells were noted in the
tubules of negative controls (Figure 4a–c). At 7 and 28 days,
the number of apoptotic cells in tubules was significantly
higher in the p35-NTN mice than that in the gGT.Cre;p35-
NTN mice, respectively, as well as in the negative controls
(Figure 4a and c). In contrast, at the same time points, the
increases in the number of apoptotic tubular cells were not
significant in the gGT.Cre;p35-ADR mice and p35-ADR mice
compared with the negative controls, and were also not
different from each other (Figure 4b and c). The number of
apoptotic glomerular cells was significantly increased in the
nephritic and nephrotic kidneys at 7 and 28 days, which were
not altered by p35 expressed in the tubules (Figure 4a and d).
Immunoblotting with an anti-caspase-3 antibody showed
that protein levels of an active subunit of cleaved caspase-3
(B20 kDa) were significantly higher in the D7 and D28
nephritic kidneys of p35-NTN mice than those of gGT.Cre;
p35-NTN mice (Figure 4e). In contrast, no differences in
those levels were seen in the D7 and D28 nephrotic kidneys
of gGT.Cre;p35-ADR and p35-ADR mice (Figure 4e). The
results of caspase-3 activation in Figure 4e were compatible
with those of apoptotic cells in the tubules in Figure 4a–c.
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DISCUSSION
Apoptosis, a form of programmed cell death, is believed
to delete excessive, damaged, or nonfunctioning cells and
infiltrating inflammatory cells for the resolution of glomer-
ulonephritis.18 In contrast, continuous and inappropriate cell
loss by disregulated apoptosis may be harmful, as suggested
in various models of progressive kidney diseases such as
NTN,10 polycystic kidney disease,8 and subtotal nephrectomy
models.19 Therefore, timely and spatially dependent roles
of apoptosis in the progressive kidney diseases should be
identified before application of an antiapoptosis strategy into
clinical nephrology.
In the NTN model, we demonstrated that inhibition
of caspase activation in proximal tubules from the onset
of disease significantly attenuated interstitial inflammatory
and fibrotic changes, which slowed deterioration of renal
function. One of the most striking upregulated pro-
inflammatory cytokines in the NTN kidneys is TNF-a
following activation of the nuclear factor-kB pathway.20
TNF-a increases the expressions of TNF-like weak inducer of
apoptosis (TWEAK) receptor, Fas, Bax, and Smac/DIABLO
while decreasing BclxL in tubular epithelial cells.21 TWEAK,
in the presence of TNF-a and interferon-g, induces apop-
tosis in proliferating tubular cells. Cells within the damaged
glomerulus in the NTN model are thought to produce
TNF-a, which in combination with other inflammatory
substances and urinary proteins subsequently causes apop-
tosis and proinflammatory and profibrogenic processes in
the tubular epithelium.21–25 In this study, p35 expressed in
the tubules significantly reduced the number of apoptotic
cells in tubules, but not in glomeruli, in the NTN model.
Conceivably, this could be due to the inhibition of apoptosis-
promoting caspase-3 activated by TNF-a, which in turn
contributed to attenuation of tubular degeneration
in the D7 and D28 nephritic kidneys of gGT.Cre;p35-NTN
mice.
The activation of the initiator caspase-1 takes place in a
complex that was labeled as an inflammasome.6 The
inflammasome is an intracellular, multiprotein complex
containing caspase-1. Caspase-1 regulates the release of
proinflammatory cytokines such as IL-1b and IL-18 in
response to exogenous pathogens (pathogen-associated
molecular patterns) and endogenous danger signals (danger-
associated molecular patterns) from damaged or dying cells.6
Recently, the role of the inflammasome in renal injury has
also been studied.26 Experiments with mice deficient for
NLRP3, another component of the inflammasome, demon-
strated that the NLRP3 inflammasome contributes to renal
inflammation in ischemia–reperfusion injury and obstructive
nephropathy.27,28 Although we did not directly measure
inflammasome formation in this study, p35 expressed in the
tubules significantly inhibited the formation of an active
subunit of IL-1b at 28 days in the gGT.Cre;p35-NTN mice
and attenuated interstitial inflammation. This suggests that
tubular caspase-1 activated by danger-associated molecular
patterns such as adenosine triphosphate, uric acid crystals,
biglycan, heat shock protein 60, and reactive oxygen species,
some of which operate through Toll-like receptors, in the
nephritic kidneys significantly contributes to interstitial
inflammation.26,29,30 This was compatible with the results
of a previous study in which treatment with soluble IL-1
receptor, an antagonist against active IL-1b, significantly
attenuated tissue inflammation in the NTN model.31
Apoptosis itself was revealed to be a crucial event that can
initiate ischemia–reperfusion-induced inflammation in the
kidney via posttranslational processing of the endothelial
monocyte–activating polypeptide II and subsequent influx of
leukocytes into the kidney.4 In addition, apoptotic cells
release MCP-1 to promote the recruitment of monocytes at
the site of apoptosis.32 Thus, p35 expression in the tubules
reduced the number of apoptotic tubular cells in the D7 and
D28 nephritic kidneys of gGT.Cre;p35-NTN mice, which
might also contribute to attenuation of interstitial inflam-
mation. Inflammatory cells infiltrating into the peritubular
interstitium further promoted cell influx and interstitial
inflammation directly via the production of proinflammatory
substances, and indirectly via enhancing the proinflamma-
tory process including pan-caspase activation in the tubular
epithelium, resulting in a vicious cycle.25 Therefore, p35
expressed in the tubules could significantly attenuate inter-
stitial inflammation in the nephritic kidneys by terminating
this vicious cycle via pan-caspase inhibition.
In this study, p35 expressed in the tubules significantly
attenuated not only inflammation but also fibrogenesis in the
interstitium of kidneys of gGT.Cre;p35-NTN mice. This
may be accounted for by the simple fact that attenuation of
early interstitial inflammation resulted in the reduction of
subsequent fibrogenesis, as fibrosis develops secondarily
Figure 1 |Renal pathology in cGT.Cre;p35 mice with nephrotoxic serum nephritis (NTN) and adriamycin nephropathy (ADR). (a) p35
protein (in red) was expressed exclusively in the tubular epithelium in the normal and diseased kidneys of gGT.Cre;p35 mice (Alexa Fluor
555; original magnification  200). (b) Levels of p35 mRNA were significantly higher in the normal and diseased kidneys of gGT.Cre;p35
mice than in p35 mice. Histopathology of the (c) D7 and D28 NTN and (d) ADR kidneys of p35 and gGT.Cre;p35 mice (Masson’s trichrome
stain; original magnification  200). (e) Tubular degeneration index. Tubular degeneration found in the D7 and D28 nephritic kidneys of
p35-NTN mice was significantly attenuated in those of gGT.Cre;p35-NTN mice, whereas advanced tubular degeneration was found in the D7
and D28 nephrotic kidneys of p35-ADR and gGT.Cre;p35-ADR mice. (f) Interstitial fibrosis index. Interstitial fibrosis found in the D7 and D28
nephritic kidneys of p35-NTN mice was significantly attenuated in those of gGT.Cre;p35-NTN mice, whereas progressive interstitial fibrosis was
found in the D7 and D28 nephrotic kidneys of both p35-ADR and gGT.Cre;p35-ADR mice. (g) Glomerular damage index. Progressive glomerular
damage was found in the D7 and D28 nephritic kidneys of p35-NTN and gGT.Cre;p35-NTN mice, as well as in the D7 and D28 nephrotic kidneys
of p35-ADR and gGT.Cre;p35-ADR mice. The data shown in e, f, and g were obtained from six independent mice. *Po0.05; NS, not statistically
significant. GAPDH, glyceraldehyde 3-phosphate dehydrogenase; NC, negative control.
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because of inflammation.24,25 Recently, apoptosis has been
identified to be directly involved in organ fibrogenesis.33–35
By engulfing apoptotic cells, reticuloendothelial system
cells such as hepatic stellate cells can produce transforming
growth factor-b1, an efficient profibrogenic growth factor,
and likely contribute to tissue fibrogenesis.33 In addition,
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Kodama et al.34 reported that some hepatocytes expressing
p53 underwent apoptosis and were phagocytosed by hepatic
stellate cells, whereas others produced profibrogenic con-
nective tissue growth factor (CCN2/CTGF), jointly resulting
in liver fibrogenesis in TG mice in which albumin
promoter–driven p53 expression localized to the hepatocytes.
In the nephritic kidneys, apoptotic tubular cells are likely
phagocytosed by infiltrating monocytes, as well as adjacent,
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kidney injury molecule-1þ (KIM-1þ ) tubular cells,36 which
likely turn to be profibrogenic and contribute to interstitial
fibrogenesis. Caspase-3 activation in apoptotic endothelial
cells also triggers the export of CCN2, which in turn pro-
motes tissue fibrogenesis.35 Therefore, p35 expressed in the
tubules reduced tubular cell apoptosis/phagocytosis and sub-
sequent interstitial fibrosis in the gGT.Cre;p35-NTN mice.
In contrast to the NTN model, pan-caspase activation in
the tubular epithelium seemed to contribute little to
interstitial inflammation and fibrogenesis in the ADR model,
Figure 2 |Renal inflammation in cGT.Cre;p35 mice with nephrotoxic serum nephritis (NTN) and adriamycin nephropathy (ADR).
Infiltration of F4/80þ monocytes (in red) in the D7 and D28 (a) NTN and (b) ADR kidneys of p35 and gGT.Cre;p35 mice (Alexa Fluor 555;
original magnification  200). (c) The number of F4/80þ monocytes in the interstitium was significantly lower in the D28 nephritic kidneys
of gGT.Cre;p35-NTN mice than in p35-NTN mice, whereas monocyte infiltration showed no differences in the D7 and D28 nephrotic kidneys
between p35-ADR and gGT.Cre;p35-ADR mice. (d) Levels of mRNAs encoding proinflammatory genes in the NTN and ADR kidneys of p35
and gGT.Cre;p35 mice. Levels of monocyte chemoattractant protein-1 (MCP1) and tumor necrosis factor-a (TNF-a) mRNAs were significantly
increased in the D7 nephritic kidneys of p35 mice, which then slightly decreased by day 28. p35 expressed in the tubules significantly
suppressed increases in those levels in the gGT.Cre;p35-NTN mice. In contrast, levels of such proinflammatory mRNAs were gradually
increased in the D7 and D28 nephrotic kidneys of both p35-ADR and gGT.Cre;p35-ADR mice. (e) Protein levels of an active subunit of
interleukin (IL)-1b. Short, active subunit of IL-1b proteins (B17 kDa) were significantly decreased in the D28 nephritic kidneys of
gGT.Cre;p35-NTN mice compared with those of p35-NTN mice. In contrast, IL-1b activation was not affected by p35 expressed in the tubules
in the D7 and D28 nephrotic kidneys of p35-ADR and gGT.Cre;p35-ADR mice. The data shown in c, d, and e were obtained from six
independent mice. *Po0.05; NS, not statistically significant. GAPDH, glyceraldehyde 3-phosphate dehydrogenase; hpf, high-power field;
NC, negative control.
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Figure 3 |Renal fibrogenesis in cGT.Cre;p35 mice with nephrotoxic serum nephritis (NTN) and adriamycin nephropathy (ADR).
Development of FSP1þ fibroblasts (in red) in the D7 and D28 (a) NTN and (b) ADR kidneys of p35 and gGT.Cre;p35 mice (Alexa Fluor 555;
original magnification  200). (c) The number of FSP1þ fibroblasts in the interstitium was significantly lower in the D28 nephritic kidneys
of gGT.Cre;p35-NTN mice than in p35-NTN mice, whereas fibroblast development was not affected by p35 expressed in the tubules in
the D7 and D28 nephrotic kidneys of p35-ADR and gGT.Cre;p35-ADR mice, respectively. (d) Levels of mRNAs encoding profibrogenic
genes in the NTN and ADR kidneys of p35 and gGT.Cre;p35 mice. Levels of plasminogen activator inhibitor-1 (PAI-1), fibronectin EIIIA
isoform (FN-EIIIA), and a1 procollagen type I (a1COLI) mRNAs were significantly higher in the D7 and D28 nephritic kidneys of p35-NTN mice
than in the gGT.Cre;p35-NTN mice. Levels of transforming growth factor-b1 (TGF-b1), PAI-1, CCN2, and a1COLI mRNAs were significantly
higher in the D28 nephrotic kidneys of both p35-ADR and gGT.Cre;p35-ADR mice, which were not significantly altered by p35 expressed in
the tubules. The data shown in c and d were obtained from six independent mice. *Po0.05; NS, not statistically significant. GAPDH,
glyceraldehyde 3-phosphate dehydrogenase; hpf, high-power field; NC, negative control.
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as p35 expressed in the tubules did not affect such interstitial
alterations in the D7 and D28 nephrotic kidneys of gGT.Cre;
p35-ADR mice compared with those of p35-ADR mice.
Incidence of apoptosis in the tubular cells was significantly
lower in the ADR nephrotic kidneys than in the NTN
nephritic kidneys in this study, which could partially be
accounted for by mild increases in TNF-a expression in
the nephrotic kidneys. In addition, protein levels of the active
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IL-1b subunit were not altered in the nephrotic kidneys,
suggesting that active danger-associated molecular patterns
were not involved in the nephrotic kidneys to activate
caspase-1. Pan-caspase inhibition may affect the disease
process in another pathway via acceleration of necrosis,
as caspase-8 was recently discovered to cleave receptor-
interacting protein kinase proteins to suppress their execu-
tion of necrosis.37 If it was true in the ADR nephrotic
kidneys, accelerated necrosis might cancel out the beneficial
effects of p35 in this study. However, as the number of
necrotic cells was not counted, this scenario remains
speculative. Regardless, all of these issues lead us to a notion
that pan-caspase inhibition from the onset of disease is
unlikely to result in preventive/therapeutic effects on the mild
inflammation and steadily progressive fibrosis in the inter-
stitium of ADR nephrotic kidneys. In addition, pathways
other than caspase activation in the tubules were suggested to
have a role in the mediation of glomerular damage to the
tubulointerstitial changes in the ADR.
Different mouse strains were used to generate NTN and
ADR models in this study by selecting strains most
susceptible to each disease. We previously demonstrated
that the genetic background of the mouse significantly
affects renal fibrogenesis.38 The possibility remains that this
strain difference influenced the contribution of the tubular
epithelium of apoptosis/caspase activities to renal fibro-
genesis between NTN (in SJL mice) and ADR (in 129 mice).
The present study suggests that early pan-caspase activa-
tion in the tubular epithelium is a crucial event in the process
that initiates interstitial inflammation and subsequent fibro-
genesis in the rapidly progressive, nephritic diseases such
as NTN, but not in the constant, monotonous advancement
of nephrotic diseases such as ADR. This puts forth new and
important opportunities to prevent acute exacerbations
in chronic kidney diseases. Chronic glomerulonephritis as
in immunoglobulin A nephropathy, and even nephrotic
syndrome as in membranous nephropathy, can be transiently
exacerbated during episodes of systemic inflammation such
as viral infection.39 The abrogation of pan-caspase activation
exclusively in the tubular epithelium during such transient
exacerbation periods could prevent further deterioration of
renal function after the episode. New anti-pan-caspase sub-
stances currently under investigation1,40 may provide new
therapeutic means to treat these conditions.
MATERIALS AND METHODS
TG animals
Two sets of TG mice were used in this study. The gGT.Cre mice
express Cre recombinase under the control of the gGT promoter
mainly in tubular epithelia. The p35 mice were a generous gift from
Professor M. Miura (Department of Genetics, Graduate School of
Pharmaceutical Sciences, University of Tokyo).15 In the p35 mice,
the p35 gene coding a baculovirus-derived, pan-caspase inhibitor
protein p35 was separated from the universal CAG promoter
by a floxed STOP sequence. All of these mice were back-crossed to
SJL and 129 mice more than 10 times before experiments. TG
protocols were approved by the Institutional Animal Care and
Use Committee at the Saitama Medical University. DNA was
extracted from tail biopsies from gGT.Cre, p35, and gGT.Cre;p35
mice, and genotyping PCR was performed with an Extract-N-Amp
Tissue PCR Kit (XNAT2; Sigma, St. Louis, MO) according to the
manufacturer’s instructions. The following PCR primers and
annealing temperatures were used. gGT.Cre: Cre-FW 50-AGGTGT
AGAGAAGGCACTTAGC-30, Cre-RV 50-CTAATCGCCATCTTC
CCAGCAGG-30, 63 1C; p35: p35-FW 50-TGGATGGATTCCACG
ATAGC-30, p35-RV 50-TGCACACTCTCCACGTAAGC-30, 55 1C.
Cycle programs were performed in a thermocycler (iCycler;
Bio-Rad Japan, Tokyo, Japan). All primers were started with 4 min
at 95 1C, followed by 35 cycles for 1 min at 95 1C, 1 min at the
primer’s appropriate annealing temperature, and 1 min at 72 1C,
finishing with 5 min at 72 1C. Products were analyzed by electro-
phoresis in 1% agarose using tris–acetate–EDTA buffer.
In vivo experiments
Six male, 5- to 6-week-old mice from each group of TG mice such as
gGT.Cre;p35 and p35 mice were used to generate the NTN and
ADR models. TG mice in the SJL background were used for the
NTN model, whereas those in the 129 background were for the
ADR model as the mouse strains most susceptible to each disease.
Generation of the NTN and ADR models was reported in detail
previously.13,14 The p35 mice with or without such manipulation
were used as the positive and the negative controls, respectively.
At 7 and 28 days after NTN and ADR generation, we confirmed the
development of early and advanced pathological changes in
those diseased kidneys in preliminary experiments, and thus we
used these protocols in this study. At these time points, mice were
killed after collection of serum and urine samples, and kidney tissues
were harvested for RNA and protein extraction, and paraformalde-
hyde fixation for paraffin blocks. Animal care and treatment
were conducted in accordance with the institutional guidelines that
adhered to the National Institutes of Health Guide for the Care
and Use of Laboratory Animals. Serum creatinine levels were
measured with an auto-analyzer (Dri-Chem 3000; Fujifilm, Tokyo,
Figure 4 |Tubular cell apoptosis in cGT.Cre;p35 mice with nephrotoxic serum nephritis (NTN) and adriamycin nephropathy (ADR).
Single-stranded DNAþ (ssDNAþ ) apoptotic nuclei (in red) in the D7 and D28 (a) NTN and (b) ADR kidneys of p35 and gGT.Cre;p35 mice
(Alexa Fluor 555; original magnification  200). (c) The number of ssDNAþ apoptotic nuclei in the tubules was significantly lower in the
D7 and D28 nephritic kidneys of gGT.Cre;p35-NTN mice than in p35-NTN mice, respectively, whereas no differences were seen in tubular
cell apoptosis in the D7 and D28 nephrotic kidneys between p35-ADR and gGT.Cre;p35-ADR mice. (d) The number of apoptotic glomerular
cells were significantly increased in the D7 and D28 NTN nephritic, but not ADR nephrotic, kidneys of both p35 and gGT.Cre;p35 mice
at 7 and 28 days, which were not significantly altered by p35 expressed in the tubules. (e) Protein levels of an active subunit of caspase-3
(Casp-3). Short, active subunits of caspase-3 proteins (B20 kDa) were significantly decreased in the D7 and D28 nephritic kidneys of
gGT.Cre;p35-NTN mice under those of p35-NTN mice, respectively, whereas no significant differences were seen in caspase-3 activation
in the D7 and D28 nephrotic kidneys between p35-ADR and gGT.Cre;p35-ADR mice. The data shown in c–e were obtained from six
independent mice. *Po0.05; G, glomerulus; NS, not statistically significant. hpf, high-power field; NC, negative control.
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Japan). Urinary protein and creatinine concentrations were
measured by using a protein assay kit (Thermo Fisher Scientific,
Waltham, MA) and a creatinine HA test kit (Wako Pure Chemical,
Osaka, Japan), respectively.
Morphological examination and Immunohistochemistry
Sections (4 mm) cut from paraffin-embedded kidneys were
processed for Masson’s trichrome staining. The number of cortical
tubules suffering from degeneration including cast formation,
atrophy, dilatation, and vacuolar change was counted among 10
tubules in 10 high-power ( 200) cortical fields, and the tubular
degeneration indices were expressed as the percentage of affected
tubules in each kidney section. Interstitial fibrosis was quantitatively
determined with the Mac SCOPE software version 2.5 (Mitani,
Fukui, Japan) in 10 high-power ( 200) cortical fields, and the
interstitial fibrosis indices were expressed as the mean percentage
area in blue per cortical field in Masson’s trichrome–stained
sections.13 Glomerular damage such as sclerosis and crescent
formation was quantitatively determined with the Mac SCOPE
software in 30 glomeruli, and the glomerular damage indices were
expressed as the mean percentage of sclerotic/crescentic area per
glomerulus.41 For immunohistochemistry, the antibodies against
p3515 (a generous gift from Professor M. Miura), single-
stranded DNA17 (18731; Immuno-Biological Laboratories, Fujioka,
Japan), mouse monocytes (F4/80; AbD Serotec, Oxford, UK),
and fibroblasts (FSP1)42 were diluted (1:400) into 1% bovine serum
albumin in phosphate-buffered saline as the blocking buffer,
and then applied on the sections for 8 h. Signals were amplified
using the TSA kit (Molecular Probe/Invitrogen, Carlsbad, CA) and
labeled using Alexa Fluor 555 (Molecular Probe) according to a
conventional indirect method. Negative-control sections were
treated as described above, but the primary antibody was omitted.
YO-PRO-1 (Molecular Probe) was used to detect the nuclei. A
confocal laser scanning microscope (FV1000; Olympus, Tokyo,
Japan) was used for data acquisition. The numbers of single-
stranded DNAþ nuclei in the tubules and in the glomeruli, and F4/
80þ monocytes and FSP1þ fibroblasts in the interstitium, were
counted in 10 microscopic fields using a  40 objective lens, and
their indices were expressed as the mean number per field.
Real-time quantitative RT-PCR
We performed RNA preparation and quantitative PCR as described
previously.13 The primers used were as follows: p35 primer, FW
50-TGTCCCAGACGATTATTCGAG-30, RV 50-GTTTTGTCAATTGC
GTGTTCA-30; MCP-1 primer, FW 50-CTCTCTTCCTCCACCAC
CAT-30, RV 50-ACTGCATCTGGCTGAGCCA-30; TNF-a primer, FW
50-TCTTCTCATTCCTGCTTGTGG-30, RV 50-GGTCTGGGCCATA
GAAACTGA-30; transforming growth factor-b1 primer, FW 50-CAG
TGGCTGAACCAAGGAGAC-30, RV 50-ATCCCGTTGATTTCCACG
TG-30; CCN2 primer, FW 50-GTGGAATATTGCCGGTGCA-30, RV
50-CCATTGAAGCATCTTGGTTCG-30; PAI-1 primer, FW 50-AGG
ATCGAGGTAAACGAGAGC-30, RV 50-GCGGGCTGAGATGACA
AA-30; FN-EIIIA primer, FW 50-ATCCGGGAGCTTTTCCCTG-30,
RV 50-TGCAAGGCAACCACACTGAC-30; COLI primer, FW 50-TGT
AAACTCCCTCCACCCCA-30, RV 50-TCGTCTGTTTCCAGGGTT
GG-30; and GAPDH primer, FW 50-TGCAGTGGCAAAGTGGAG
ATT-30, RV 50-TTGAATTTGCCGTGAGTGGA-30. All of these
oligodeoxynucleotides were designed using the Primer Express
software (Perkin Elmer, Foster City, CA). Preliminary real-time PCR
experiments in which these primer sets were used yielded
appropriately sized, single products.
Immunoblotting
Immunoblotting was performed using protein samples extracted
from kidney tissues, as described previously.43Anti-IL-1b (NIBSC,
Potters Bar, UK), anti-caspase-3 (BD Transduction, Franklin Lakes,
NJ), and anti-actin (sc-8432; Santa Cruz Biotechnology, Santa Cruz,
CA) were used as the primary antibodies in this study. The
immunoreactive proteins were detected by enhanced chemilumines-
cence and captured on X-ray film. Molecular weight standards
(LC5602; Invitrogen) were run with each blot. The intensity of each
band was measured using the Mac SCOPE software.
Statistical analysis
Values are presented as the mean±s.d. Statistical differences
between groups were evaluated by analysis of variance, followed
by a Bonferroni/Dunnett’s test. P-values that were ±0.05 were
considered to be statistically significant.
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